• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

9.200 -0.290 (-3.06%)
Streaming Delayed Price Updated: 3:59 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CNS Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
The Global Market for Brain Tumor Treatments Will Reach $7.15 Billion by 2035
April 17, 2025
Via Investor Brand Network
Top stock movements in today's session.
April 15, 2025
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes. 
Via Chartmill
The market is filled with gapping stocks in Tuesday's session.
April 15, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday. 
Via Chartmill
Study Uncovers Drivers of Brain Tumor Growth, Could Open New Treatment Approaches
April 07, 2025
Via Investor Brand Network
CNS Pharmaceuticals Reports Full Year 2024 Financial Results
April 01, 2025
Via ACCESS Newswire
CNS Pharmaceuticals Provides Update on Current Cash Position and NASDAQ Listing
February 26, 2025
Via ACCESS Newswire
Pitt Researchers Develop Diagnostic Tool for Profiling Pediatric Brain Cancers
April 02, 2025
Via Investor Brand Network
InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Advances TPI 287 for GBM, Ends 2024 with Strong Cash Position
April 01, 2025
Via Investor Brand Network
Firefighters Have an Increased Chance of Having Gene Mutations Associated with Brain Cancer, Study Says
March 27, 2025
Via Investor Brand Network
Top movers analysis one hour before the close of the markets on 2025-03-25: top gainers and losers in today's session.
March 25, 2025
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes. 
Via Chartmill
CNS Pharmaceuticals to Present at the 18th Annual European Life Sciences CEO Forum
February 20, 2025
Via ACCESS Newswire
Which stocks are experiencing notable movement on Tuesday?
March 25, 2025
Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 25, 2025
 
Via Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
March 25, 2025
The market is buzzing with gapping stocks on Tuesday. Let's uncover which stocks are experiencing notable gaps during today's session. 
Via Chartmill
Nasdaq Gains 50 Points; US New Home Sales Rise In February
March 25, 2025
 
Via Benzinga
CNS Pharma's Cancer Drug Misses Survival Goal But May Offer Fewer Side Effects
March 25, 2025
CNS Pharmaceuticals' Berubicin trial results show a favorable safety profile with no cardiotoxicity and comparable efficacy to Lomustine in recurrent GBM. 
Via Benzinga
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Phase 2 Results for Berubicin in Glioblastoma Trial
March 25, 2025
Via Investor Brand Network
Which stocks are moving before the opening bell on Tuesday?
March 25, 2025
Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
US Stocks Mixed; Core & Main Posts Downbeat Earnings
March 25, 2025
 
Via Benzinga
CNS Pharmaceuticals Announces Primary Analysis of Berubicin in Second Line Treatment of Glioblastoma Multiforme
March 25, 2025
Via ACCESS Newswire
Wednesday's session: gap up and gap down stocks
March 19, 2025
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session. 
Via Chartmill
Why StoneCo Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket
March 19, 2025
 
Via Benzinga
Study Finds Experimental Drug Prolongs the Survival of Glioblastoma Patients
March 11, 2025
Via Investor Brand Network
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Updates Cash Position, Nasdaq Compliance, and Clinical Progress
February 26, 2025
Via Investor Brand Network
Top movers analysis one hour before the close of the markets on 2025-02-21: top gainers and losers in today's session.
February 21, 2025
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
Top movers in Friday's session
February 21, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
Gapping stocks in Friday's session
February 21, 2025
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Friday. Let's explore the market movements and identify the stocks with significant gaps. 
Via Chartmill
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at European Life Sciences CEO Forum
February 21, 2025
Via Investor Brand Network
Scientists Discover ‘Roadmap’ Followed by Aggressive Cancers to Spread
February 20, 2025
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights 2025 Outlook at Virtual Investor Conference
February 20, 2025
Via Investor Brand Network
< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap